Association Analysis of the Extended MHC Region in Celiac Disease Implicates Multiple Independent Susceptibility Loci

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 May 23

PMID 22615847

Citations 16

Authors

Richard Ahn

Yuan Chun Ding

Joseph Murray

Alessio Fasano

Peter H R Green

Susan L Neuhausen

Chad Garner

Affiliations

Soon will be listed here.

Abstract

Celiac disease is a common autoimmune disease caused by sensitivity to the dietary protein gluten. Forty loci have been implicated in the disease. All disease loci have been characterized as low-penetrance, with the exception of the high-risk genotypes in the HLA-DQA1 and HLA-DQB1 genes, which are necessary but not sufficient to cause the disease. The very strong effects from the known HLA loci and the genetically complex nature of the major histocompatibility complex (MHC) have precluded a thorough investigation of the region. The purpose of this study was to test the hypothesis that additional celiac disease loci exist within the extended MHC (xMHC). A set of 1898 SNPs was analyzed for association across the 7.6 Mb xMHC region in 1668 confirmed celiac disease cases and 517 unaffected controls. Conditional recursive partitioning was used to create an informative indicator of the known HLA-DQA1 and HLA-DQB1 high-risk genotypes that was included in the association analysis to account for their effects. A linkage disequilibrium-based grouping procedure was utilized to estimate the number of independent celiac disease loci present in the xMHC after accounting for the known effects. There was significant statistical evidence for four new independent celiac disease loci within the classic MHC region. This study is the first comprehensive association analysis of the xMHC in celiac disease that specifically accounts for the known HLA disease genotypes and the genetic complexity of the region.

Citing Articles

Interactions within the MHC contribute to the genetic architecture of celiac disease.

Goudey B, Abraham G, Kikianty E, Wang Q, Rawlinson D, Shi F PLoS One. 2017; 12(3):e0172826.

PMID: 28282431 PMC: 5345796. DOI: 10.1371/journal.pone.0172826.

Regulation of Chemokine Signal Integration by Activator of G-Protein Signaling 4 (AGS4).

Robichaux 3rd W, Branham-OConnor M, Hwang I, Vural A, Kehrl J, Blumer J J Pharmacol Exp Ther. 2017; 360(3):424-433.

PMID: 28062526 PMC: 5325072. DOI: 10.1124/jpet.116.238436.

Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus.

DAmico F, Skarmoutsou E, Lo L, Granata M, Trovato C, Rossi G Immunol Lett. 2016; 181:58-62.

PMID: 27888057 PMC: 5222889. DOI: 10.1016/j.imlet.2016.11.011.

Association between the MYO9B polymorphisms and celiac disease risk: a meta-analysis.

Liao N, Chen M, Zhao H, Xie Z Int J Clin Exp Med. 2015; 8(9):14916-25.

PMID: 26628973 PMC: 4658862.

Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.

Li Y, Li J, Zhao S, Bradfield J, Mentch F, Maggadottir S Nat Med. 2015; 21(9):1018-27.

PMID: 26301688 PMC: 4863040. DOI: 10.1038/nm.3933.

References

Stokes P, Asquith P, Holmes G, Mackintosh P, COOKE W . Histocompatibility antigens associated with adult coeliac disease. Lancet. 1972; 2(7769):162-4. DOI: 10.1016/s0140-6736(72)91330-x. View

Kaukinen K, Collin P, Mykkanen A, Partanen J, Maki M, Salmi J . Celiac disease and autoimmune endocrinologic disorders. Dig Dis Sci. 1999; 44(7):1428-33. DOI: 10.1023/a:1026612121041. View

Greco L, CORAZZA G, Babron M, Clot F, Percopo S, Zavattari P . Genome search in celiac disease. Am J Hum Genet. 1998; 62(3):669-75. PMC: 1376948. DOI: 10.1086/301754. View

King A, Fraser J, Moodie S, Curtis D, Dearlove A, Ellis H . Coeliac disease: follow-up linkage study provides further support for existence of a susceptibility locus on chromosome 11p11. Ann Hum Genet. 2001; 65(Pt 4):377-86. DOI: 10.1017/S0003480001008703. View

Polvi A, Arranz E, Fernandez-Arquero M, Collin P, Maki M, Sanz A . HLA-DQ2-negative celiac disease in Finland and Spain. Hum Immunol. 1998; 59(3):169-75. DOI: 10.1016/s0198-8859(98)00008-1. View

Sachs J, Awad J, McCloskey D, Navarrete C, Festenstein H, Elliot E . Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis. Gut. 1986; 27(5):515-20. PMC: 1433500. DOI: 10.1136/gut.27.5.515. View

Collin P, Pukkala E, Reunala T . Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut. 1996; 38(4):528-30. PMC: 1383109. DOI: 10.1136/gut.38.4.528. View

Feolo M, Fuller T, Taylor M, Zone J, Neuhausen S . A strategy for high throughput HLA-DQ typing. J Immunol Methods. 2001; 258(1-2):65-71. DOI: 10.1016/s0022-1759(01)00473-2. View

Falchuk Z, Strober W . HL-A antigens and adult coeliac disease. Lancet. 1972; 2(7790):1310. DOI: 10.1016/s0140-6736(72)92680-3. View

10.

van Heel D, Franke L, Hunt K, Gwilliam R, Zhernakova A, Inouye M . A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet. 2007; 39(7):827-9. PMC: 2274985. DOI: 10.1038/ng2058. View

11.

Garner C, Ding Y, Steele L, Book L, Leiferman K, Zone J . Genome-wide linkage analysis of 160 North American families with celiac disease. Genes Immun. 2006; 8(2):108-14. DOI: 10.1038/sj.gene.6364361. View

12.

Barcellos L, May S, Ramsay P, Quach H, Lane J, Nititham J . High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet. 2009; 5(10):e1000696. PMC: 2758598. DOI: 10.1371/journal.pgen.1000696. View

13.

Nejentsev S, Howson J, Walker N, Szeszko J, Field S, Stevens H . Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature. 2007; 450(7171):887-92. PMC: 2703779. DOI: 10.1038/nature06406. View

14.

Walker M, Murray J, Ronkainen J, Aro P, Storskrubb T, DAmato M . Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology. 2010; 139(1):112-9. PMC: 2902605. DOI: 10.1053/j.gastro.2010.04.007. View

15.

Popat S, Bevan S, Braegger C, Busch A, ODonoghue D, Falth-Magnusson K . Genome screening of coeliac disease. J Med Genet. 2002; 39(5):328-31. PMC: 1735127. DOI: 10.1136/jmg.39.5.328. View

16.

Howson J, Walker N, Clayton D, Todd J . Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab. 2009; 11 Suppl 1:31-45. PMC: 2779837. DOI: 10.1111/j.1463-1326.2008.01001.x. View

17.

Ventura A, Magazzu G, Greco L . Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology. 1999; 117(2):297-303. DOI: 10.1053/gast.1999.0029900297. View

18.

Fasano A, Berti I, Gerarduzzi T, Not T, Colletti R, Drago S . Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003; 163(3):286-92. DOI: 10.1001/archinte.163.3.286. View

19.

Mazzilli M, Ferrante P, Mariani P, Martone E, Petronzelli F, Triglione P . A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ(alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol. 1992; 33(2):133-9. DOI: 10.1016/0198-8859(92)90064-t. View

20.

Rubio-Tapia A, Kyle R, Kaplan E, Johnson D, Page W, Erdtmann F . Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009; 137(1):88-93. PMC: 2704247. DOI: 10.1053/j.gastro.2009.03.059. View